European Journal of Clinical Pharmacology

, Volume 74, Issue 3, pp 377–378 | Cite as

Warfarin resistance from primidone in patient with essential tremor

Letter to the Editor
First Online:
Received:
Accepted:
This is a preview of subscription content, log in to check access.

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Koller WC, Vetere-Overfield B (1989) Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 39(12):1587–1588.  https://doi.org/10.1212/WNL.39.12.1587 CrossRefPubMedGoogle Scholar
  2. 2.
    Deuschl G, Raethjen J, Hellriegel H, Elble R (2011) Treatment of patients with essential tremor. Lancet Neurol 10(2):148–161.  https://doi.org/10.1016/S1474-4422(10)70322-7 CrossRefPubMedGoogle Scholar
  3. 3.
    Wittkowsky AK, Boccuzzi SJ, Wogen J, Wygant G, Patel P, Hauch O (2004) Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 24:1168–1674Google Scholar
  4. 4.
    Package insert, primidone, Qualitest Pharmaceuticals 2010Google Scholar
  5. 5.
    Battino D, Avanzini G, Bossi L, Croci D, Cusi C, Gomeni C, Moise A (1983) Plasma levels of primidone and its metabolite phenobarbital: effect of age and associated therapy. Ther Drug Monit 5(1):73–79.  https://doi.org/10.1097/00007691-198303000-00006 CrossRefPubMedGoogle Scholar
  6. 6.
    Chen Y, Ferguson SS, Negishi M, Goldstein JA (2004) Induction of human CYP2C9 by rifampicin, hyperforin and phenobarbital is medicated by pregnane X receptor. J Pharmacol Exp Ther 308(2):495–501.  https://doi.org/10.1124/jpet.103.058818 CrossRefPubMedGoogle Scholar
  7. 7.
    MacDonald MG, Robinson DS, Sylwester D, Jaffe JJ (1969) The effects of phenobarbital, choral betaine, and glutethimide administration on warfarin plasma levels and hypoprothrombinemic responses in man. Clin Pharmacol Ther 10(1):80–84.  https://doi.org/10.1002/cpt196910180 CrossRefPubMedGoogle Scholar
  8. 8.
    Udall JA (1975) Clinical implications of warfarin interactions with five sedatives. Am J Cardiol 35(1):67–71.  https://doi.org/10.1016/0002-9149(75)90560-3 CrossRefPubMedGoogle Scholar
  9. 9.
    Clark NP, Hoang K, Delate T, Horn JR, Witt DM (2017) Warfarin interaction with hepatic cytochrome P-450 enzyme-inducing anticonvulsants. Clin Appl Thromb Hemost Jan 1:1076029616687849.  https://doi.org/10.1177/1076029616687849 Google Scholar
  10. 10.
    Gironell A, Kulisevsky J, Barbanoj M, Lopez-Villegas D, Hernandez G, Pascuai-Sedano B (1999) A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 56(4):475–480.  https://doi.org/10.1001/archneur.56.4.475 CrossRefPubMedGoogle Scholar
  11. 11.
    Bruno E, Nicoletti A, Quattrocchi G, Allegra R, Filippini G, Colosimo C, Zappia M (2017) Topiramate for essential tremor. Cochrane Database Syst Rev 4:CD009683.  https://doi.org/10.1002/14651858.CD009683.pub2 PubMedGoogle Scholar
  12. 12.
    Stollberger C, Finsterer J (2016) Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs. Epilepsy Res 126:98–101.  https://doi.org/10.1016/j.eplepsyres.2016.06.003 CrossRefPubMedGoogle Scholar

Copyright information

© This is a U.S. government work and its text is not subject to copyright protection in the United States; however, its text may be subject to foreign copyright protection 2017

Authors and Affiliations

  1. 1.Northern Arizona VA Health Care SystemPrescottUSA

Personalised recommendations